Sagimet Biosciences Inc. (SGMT)
(Delayed Data from NSDQ)
$8.96 USD
+0.51 (6.04%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $8.94 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Sagimet Biosciences Inc. has a market cap of $259.20M, which represents its share price of $8.45 multiplied by its outstanding shares number of 30.67M. As a small-cap company, SGMT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SGMT 8.96 +0.51(6.04%)
Will SGMT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SGMT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGMT
What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now?
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know
SGMT: What are Zacks experts saying now?
Zacks Private Portfolio Services
SGMT Stock Up 12.6% on FDA Fast Track for Liver Disease Drug
Other News for SGMT
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference | ...
Sagimet Biosciences (SGMT) Gains on Canaccord Genuity's Positive Outlook
Sagimet gains as Canaccord Genuity starts with Buy on potential against MASH
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
Sagimet Biosciences (SGMT) Receives 'Buy' Rating from Canaccord Genuity | SGMT Stock News